Minor Suspected

描述

Valsartan may slightly increase digoxin plasma levels by reducing its renal clearance; the interaction is generally modest.

机制

Angiotensin II promotes renal tubular secretion of digoxin; ARB-mediated angiotensin II blockade may reduce this secretion, marginally raising digoxin levels.

临床意义

Small increase in digoxin exposure; rarely clinically significant unless patient is already at the upper end of the therapeutic range.

处理措施

Monitor digoxin levels when initiating valsartan in digitalized patients; adjust dose if levels exceed 1.2 ng/mL.

医疗免责声明

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.